Kakeru Hisakane
-
- Lung Cancer Treatments and Mutations 16
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 10
- Lung Cancer Diagnosis and Treatment 10
- Pleural and Pulmonary Diseases 4
- Medical Imaging and Pathology Studies 3
-
- Cancer Immunotherapy and Biomarkers 10
- Lung Cancer Research Studies 8
-
- Sarcoidosis and Beryllium Toxicity Research 3
Kakeru Hisakane
30 papers receiving 334 citations
Peers
Comparison fields: 5 of 48
- Pulmonary and Respiratory Medicine 215
- Oncology 179
- Cancer Research 67
- Molecular Biology 77
- Otorhinolaryngology 4
Countries citing papers authored by Kakeru Hisakane
This map shows the geographic impact of Kakeru Hisakane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kakeru Hisakane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kakeru Hisakane more than expected).
Fields of papers citing papers by Kakeru Hisakane
This network shows the impact of papers produced by Kakeru Hisakane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kakeru Hisakane. The network helps show where Kakeru Hisakane may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kakeru Hisakane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 9 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 8 | |
| 12 | 2022 | 5 | |
| 13 | 2021 | 0 | |
| 14 | 2019 | 22 | |
| 15 | 2019 | 31 | |
| 16 | 2018 | 5 | |
| 17 | 2017 | 10 | |
| 18 | 2016 | 17 | |
| 19 | 2016 | 5 | |
| 20 | 2015 | 6 |
About Kakeru Hisakane
Kakeru Hisakane is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 35 papers that have together received 336 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Research Studies (8 papers), Pleural and Pulmonary Diseases (4 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers) and Medical Imaging and Pathology Studies (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (215 citations), Oncology (179 citations) and Cancer Research (67 citations). Kakeru Hisakane has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Akihiko Gemma, Masahiro Seike, Rintaro Noro, Teppei Sugano, Satoshi Takahashi, Kaoru Kubota, Susumu Takeuchi, Yuji Minegishi, Takeru Kashiwada and Kuniko Matsuda. Their work appears in journals such as Anticancer Research, Lung Cancer, Translational Lung Cancer Research, Medicine and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.